Skip to main content
Top
Published in: International Urology and Nephrology 6/2018

01-06-2018 | Urology - Original Paper

Additional treatments, satisfaction, symptoms and quality of life in women 1 year after vaginal and abdominal pelvic organ prolapse repair

Authors: Laura N. Nguyen, Morgan Gruner, Kim A. Killinger, Kenneth M. Peters, Judith A. Boura, Michelle Jankowski, Larry T. Sirls

Published in: International Urology and Nephrology | Issue 6/2018

Login to get access

Abstract

Objectives

To evaluate additional treatments, symptoms, satisfaction and quality of life 1 year after vaginal and abdominal pelvic organ prolapse (POP) repair.

Methods

Adult women enrolled in a prospective POP database were reviewed. Baseline and outcomes data 1 year after surgery were collected including the Pelvic Floor Distress Inventory (PFDI) and mailed surveys. Data were analyzed with descriptive statistics, Fisher’s exact tests and t tests.

Results

Of 222 women, 147 (66%) had vaginal and 75 (34%) had abdominal repair. Vaginal group patients were older (64.1 vs. 59.7 years; p = 0.003), but other demographic characteristics did not differ. Vaginal group patients had lower baseline anterior and apical prolapse grades (anterior 2.7 vs. 3.1, p = 0.003; apical 2.1 vs. 3.1, p < 0.001). Baseline PFDI scores were similar. Scores improved significantly for both groups after 1 year, but 1-year PFDI scores were significantly higher in the vaginal group (45.6 vs. 32.6, p = 0.032). Scores were not different when adjusted for age and prolapse grade (p = 0.24). At 1 year, most patients in the vaginal and abdominal groups reported moderately/markedly improved overall symptoms (72/108 vs. 50/60, p = 0.030) and quality of life (89/101 vs. 54/59, p = 0.601). Most were satisfied with surgery (68/101 vs. 48/59, p = 0.067). Retreatment rates (pelvic floor physical therapy, medications, coping strategies, surgical procedures) were similar (34/109 vs. 15/62, p = 0.381). Vaginal mesh use did not affect additional treatments, patient satisfaction or symptoms.

Conclusions

Although symptoms improve and most women are satisfied with surgery, about one in four women have additional therapy in the first year after POP repair.
Literature
1.
go back to reference Jelovsek JE, Maher C, Barber MD (2007) Pelvic organ prolapse. The Lancet 369(9566):1027–1038CrossRef Jelovsek JE, Maher C, Barber MD (2007) Pelvic organ prolapse. The Lancet 369(9566):1027–1038CrossRef
3.
go back to reference Olsen AL, Smith VJ, Bergstrom JO et al (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89(4):501–506CrossRefPubMed Olsen AL, Smith VJ, Bergstrom JO et al (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89(4):501–506CrossRefPubMed
4.
go back to reference Abdel-Fattah M, Familusi A, Fielding S et al (2011) Primary and repeat surgical treatment for female pelvic organ prolapse and incontinence in parous women in the UK: a register linkage study. BMJ Open 1(2):e000206CrossRefPubMedPubMedCentral Abdel-Fattah M, Familusi A, Fielding S et al (2011) Primary and repeat surgical treatment for female pelvic organ prolapse and incontinence in parous women in the UK: a register linkage study. BMJ Open 1(2):e000206CrossRefPubMedPubMedCentral
5.
go back to reference Subak LL, Waetjen LE, van den Eeden S et al (2001) Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol 98(4):646–651PubMed Subak LL, Waetjen LE, van den Eeden S et al (2001) Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol 98(4):646–651PubMed
6.
go back to reference Sung VW, Washington B, Raker CA (2010) Costs of ambulatory care related to female pelvic floor disorders in the United States. Am J Obstet Gynecol 202(5):483e1-4CrossRef Sung VW, Washington B, Raker CA (2010) Costs of ambulatory care related to female pelvic floor disorders in the United States. Am J Obstet Gynecol 202(5):483e1-4CrossRef
7.
go back to reference Maher CF, Qatawneh AM, Dwyer PL et al (2004) Abdominal sacral colpopexy or vaginal sacrospinous colpopexy for vaginal vault prolapse: a prospective randomized study. Am J Obstet Gynecol 190(1):20–26CrossRefPubMed Maher CF, Qatawneh AM, Dwyer PL et al (2004) Abdominal sacral colpopexy or vaginal sacrospinous colpopexy for vaginal vault prolapse: a prospective randomized study. Am J Obstet Gynecol 190(1):20–26CrossRefPubMed
8.
go back to reference Altman D, Vayrynen T, Engh ME et al (2011) Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse. N Engl J Med 364(19):1826–1836CrossRefPubMed Altman D, Vayrynen T, Engh ME et al (2011) Anterior colporrhaphy versus transvaginal mesh for pelvic-organ prolapse. N Engl J Med 364(19):1826–1836CrossRefPubMed
9.
go back to reference Jacquetin B, Hinoul P, Gauld J et al (2013) Total transvaginal mesh (TVM) technique for treatment of pelvic organ prolapse: a 5-year prospective follow-up study. Int Urogynecol J 24(10):1679–1686CrossRefPubMed Jacquetin B, Hinoul P, Gauld J et al (2013) Total transvaginal mesh (TVM) technique for treatment of pelvic organ prolapse: a 5-year prospective follow-up study. Int Urogynecol J 24(10):1679–1686CrossRefPubMed
10.
go back to reference Maher C, Feiner B, Baessler K et al (2016) Surgery for women with apical vaginal prolapse. Cochrane Database Syst Rev 10:CD012376PubMed Maher C, Feiner B, Baessler K et al (2016) Surgery for women with apical vaginal prolapse. Cochrane Database Syst Rev 10:CD012376PubMed
11.
go back to reference Dallenbach P, Jungo Nancoz C, Eperon I et al (2012) Incidence and risk factors for reoperation of surgically treated pelvic organ prolapse. Int Urogynecol J 23(1):35–41CrossRefPubMed Dallenbach P, Jungo Nancoz C, Eperon I et al (2012) Incidence and risk factors for reoperation of surgically treated pelvic organ prolapse. Int Urogynecol J 23(1):35–41CrossRefPubMed
12.
go back to reference Linder BJ, Chow GK, Elliott DS (2015) Long-term quality of life outcomes and retreatment rates after robotic sacrocolpopexy. Int J Urol 22(12):1155–1158CrossRefPubMed Linder BJ, Chow GK, Elliott DS (2015) Long-term quality of life outcomes and retreatment rates after robotic sacrocolpopexy. Int J Urol 22(12):1155–1158CrossRefPubMed
13.
go back to reference Bartley JM, Sirls LT, Killinger KA et al (2015) Secondary surgery after vaginal prolapse repair with mesh is more common for stress incontinence and voiding dysfunction than for mesh problems or prolapse recurrence. Int Urol Nephrol 47(4):609–615CrossRefPubMed Bartley JM, Sirls LT, Killinger KA et al (2015) Secondary surgery after vaginal prolapse repair with mesh is more common for stress incontinence and voiding dysfunction than for mesh problems or prolapse recurrence. Int Urol Nephrol 47(4):609–615CrossRefPubMed
14.
go back to reference Wu JM, Dieter AA, Pate V et al (2017) Cumulative incidence of a subsequent surgery after stress urinary incontinence and pelvic organ prolapse procedure. Obstet Gynecol 129(6):1124–1130CrossRefPubMedPubMedCentral Wu JM, Dieter AA, Pate V et al (2017) Cumulative incidence of a subsequent surgery after stress urinary incontinence and pelvic organ prolapse procedure. Obstet Gynecol 129(6):1124–1130CrossRefPubMedPubMedCentral
15.
go back to reference McLennan GP, Sirls LT, Killinger KA et al (2013) Perioperative experience of pelvic organ prolapse repair with the Prolift and Elevate vaginal mesh procedures. Int Urogynecol J 24(2):287–294CrossRefPubMed McLennan GP, Sirls LT, Killinger KA et al (2013) Perioperative experience of pelvic organ prolapse repair with the Prolift and Elevate vaginal mesh procedures. Int Urogynecol J 24(2):287–294CrossRefPubMed
16.
go back to reference Gupta P, Payne J, Killinger KA et al (2016) Analysis of changes in sexual function in women undergoing pelvic organ prolapse repair with abdominal or vaginal approaches. Int Urogynecol J 27(12):1919–1924CrossRefPubMed Gupta P, Payne J, Killinger KA et al (2016) Analysis of changes in sexual function in women undergoing pelvic organ prolapse repair with abdominal or vaginal approaches. Int Urogynecol J 27(12):1919–1924CrossRefPubMed
17.
go back to reference Barber MD, Spino C, Janz NK et al (2009) The minimum important differences for the urinary scales of the pelvic floor distress inventory and pelvic floor impact questionnaire. Am J Obstet Gynecol 200(5):580e1-7CrossRef Barber MD, Spino C, Janz NK et al (2009) The minimum important differences for the urinary scales of the pelvic floor distress inventory and pelvic floor impact questionnaire. Am J Obstet Gynecol 200(5):580e1-7CrossRef
18.
go back to reference Doaee M, Moradi-Lakeh M, Nourmohammadi A et al (2014) Management of pelvic organ prolapse and quality of life: a systematic review and meta-analysis. Int Urogynecol J 25(2):153–163CrossRefPubMed Doaee M, Moradi-Lakeh M, Nourmohammadi A et al (2014) Management of pelvic organ prolapse and quality of life: a systematic review and meta-analysis. Int Urogynecol J 25(2):153–163CrossRefPubMed
19.
go back to reference Aslam MF, Osmundsen B, Edwards SR et al (2016) Preoperative prolapse stage as predictor of failure of sacrocolpopexy. Female Pelvic Med Reconstr Surg 22(3):156–160CrossRefPubMed Aslam MF, Osmundsen B, Edwards SR et al (2016) Preoperative prolapse stage as predictor of failure of sacrocolpopexy. Female Pelvic Med Reconstr Surg 22(3):156–160CrossRefPubMed
20.
go back to reference Maher C, Feiner B, Baessler K et al (2016) Surgery for women with anterior compartment prolapse. Cochrane Database Syst Rev 11:CD004014PubMed Maher C, Feiner B, Baessler K et al (2016) Surgery for women with anterior compartment prolapse. Cochrane Database Syst Rev 11:CD004014PubMed
Metadata
Title
Additional treatments, satisfaction, symptoms and quality of life in women 1 year after vaginal and abdominal pelvic organ prolapse repair
Authors
Laura N. Nguyen
Morgan Gruner
Kim A. Killinger
Kenneth M. Peters
Judith A. Boura
Michelle Jankowski
Larry T. Sirls
Publication date
01-06-2018
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 6/2018
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-018-1846-5

Other articles of this Issue 6/2018

International Urology and Nephrology 6/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.